Artificial intelligence algorithm + human brain imaging database to measure the incidence of central nervous system diseases

The latest news, in May 2018, Shanghai Medical Technology Co., Ltd. - Dr. Brain (Dr. Brain) successfully completed the Pre-A round of financing, and obtained an exclusive investment of tens of millions of yuan from Haier Capital's Sea Cube Boat Fund. Previously, the brain doctor had been led by Dow Investment, and the investment in the angel wheel of Ai Rui Capital and Shanghai Shengxi. This round of financing is an exclusive financial advisor by Qitian Chuangfu.

Founded in April 2017, Dr. Brain was founded by Wang Silun, a neuroscientist in the United States, and Lin Zhaohan, a financial background. It is a database based on the Chinese brain model, combined with core technologies such as cloud computing and artificial intelligence. An intelligent diagnostic platform for accurate assessment of central nervous system disorders. Currently, the company has established R&D centers in Atlanta and Shenzhen, and has established business development teams in Beijing, Changsha and Shenzhen. At this stage, the main business modules of brain doctors are brain doctor cloud computing platform, Chinese population brain imaging database, artificial intelligence evaluation system and so on.

Dr. Brain Cloud uses massively parallel GPU architecture to process massive medical image data and perform accurate structural analysis, enabling doctors to obtain brain structure data accurate to millimeters.

Dr. Brain Database: The Brain Doctor System obtains a brain imaging database of the Chinese population by collecting brain MRI data from a large number of Chinese populations, which is used to accurately detect and evaluate brain morphological data of each subject, including white matter and gray matter volume, hippocampal volume. , basal ganglia, ventricular structure, abnormal white matter signals, etc., for the diagnosis of Alzheimer's disease, Parkinson's disease, epilepsy, schizophrenia, multiple sclerosis and other diseases.

Dr. Brain DeepLearning: The first application of artificial intelligence algorithms and a massive Chinese brain imaging database to predict the risk of developing central nervous system diseases such as Alzheimer's disease and Parkinson's disease. As of now, the accuracy rate of artificial intelligence algorithms developed by the team in Alzheimer's disease (AD) has exceeded 85%, the accuracy of early cognitive dysfunction (MCI) algorithm has exceeded 80%, and the Parkinson's disease (PD) algorithm is accurate. The rate exceeded 85%, and the autism artificial intelligence algorithm broke 87%.

It is reported that by the beginning of 2018, brain doctors have successfully signed cooperation agreements with more than 40 top three hospitals, and established brains in Beijing's top hospitals such as Peking Union Medical College Hospital, Tiantan Hospital, Hunan Xiangya Hospital, Wuhan Zhongnan Hospital and Tianjin Huanhu Hospital. The doctor workstation and the scientific research project in cooperation with the Zhongnan Hospital of Wuhan University have been selected into the special research and development plan of the Ministry of Science and Technology in 2018.

Dr. Wang Siren, founder and CEO of Brain Doctor, said that the funds raised in this round will be used to achieve a foundation, improve technical barriers, speed up the national layout, obtain CFDA approval as soon as possible, and start the commercialization process in advance.

Blood Collection Needle

Blood Collection Needle,disposable blood collecting needle,retraction type blood collection needle

Shandong Zhushi Pharmaceutical Group Co.,LTD , https://www.sdzs-medical.com